Viatris (VTRS) EBITDA Margin (2019 - 2026)
Viatris (VTRS) recorded quarterly EBITDA Margin of 2.27% in Q1 2026, up 56.6% quarter-over-quarter from 5.22% in Q4 2025, and up 8660.0% on a YoY basis from 0.03% in Q1 2025.
Viatris (VTRS) EBITDA Margin (2019 - 2026) Analysis & Trends
Viatris' EBITDA Margin history runs 8 years deep, the most recent figure standing at 2.27% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 8660.0% year-over-year to 2.27%; the TTM figure through Mar 2026 stood at 0.96% (up 2246.0% YoY), while the FY2025 annual figure was 18.69%, down 1876.0% from the prior year.
- EBITDA Margin was 2.27% for Q1 2026 at Viatris, up from 5.22% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 16.88% in Q1 2022 to a low of 88.87% in Q1 2025.
- Historically, EBITDA Margin has averaged 0.62% across 5 years, with a median of 5.57% in 2024.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin plunged 9443 bps in 2025, then jumped 8660 bps in 2026.
- A 5-year view of EBITDA Margin shows it stood at 5.15% in 2022, then soared by 176 bps to 3.94% in 2023, then plunged by 230 bps to 5.11% in 2024, then decreased by 2 bps to 5.22% in 2025, then jumped by 57 bps to 2.27% in 2026.
- The last three EBITDA Margin figures came in at 2.27% (Q1 2026), 5.22% (Q4 2025), and 4.77% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Viatris | - | - | 1.16 Bn | -2.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.27% |
| Dec 31, 2025 | -5.22% |
| Sep 30, 2025 | 4.77% |
| Jun 30, 2025 | 6.50% |
| Mar 31, 2025 | -88.87% |
| Dec 31, 2024 | -5.11% |
| Sep 30, 2024 | 6.02% |
| Jun 30, 2024 | -6.32% |
| Mar 31, 2024 | 5.57% |
| Dec 31, 2023 | 3.94% |
| Sep 30, 2023 | 11.48% |
| Jun 30, 2023 | 9.42% |
| Mar 31, 2023 | 10.72% |
| Dec 31, 2022 | -5.15% |
| Sep 30, 2022 | 13.73% |
| Jun 30, 2022 | 13.37% |
| Mar 31, 2022 | 16.88% |
| Dec 31, 2021 | -1.76% |
| Sep 30, 2021 | 7.88% |
| Jun 30, 2021 | -1.05% |